Vishnu Chemicals Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Market Cap: ₹4.2K Cr
Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth). Vishnu Chemicals reported over 20% year-on-year growth in both operating revenue and PAT in Q1 FY27, indicating strong growth momentum. - The company targets a 20% EBITDA margin over the long term. - Growth drivers include capacity additions in specialty chemicals (e.g., DMSO), backward integration in the barium business, scaling up of the strontium segment, and commencing South African operations expected in H2 FY27. - Shift towards higher value-added chromium derivatives is expected to improve margins. - Despite near-to-medium term headwinds from geopolitical tensions and increased logistics costs, the company remains optimistic about medium-term growth supported by diversified geography and strategic supply agreements. - Capex investments of approx.
From Vishnu Chemicals's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹635
Market Cap
₹4.2K Cr
P/E Ratio
28.3
Revenue Rank
Margin Rank
Vishnu Chemicals — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹411 Cr, net profit ₹34 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth).
- →Focus on growing specialty chemicals like DMSO with capex of over INR 200 crores underway.
- →Expanding backward integration in barium business to improve raw material security and product quality.
- →Scaling up production in strontium business aiming to increase capacity utilization from 50% to 65-75% by year-end.
- →Strategic shift toward higher value-added chromium derivatives (like Chromic Acid, Chrome Oxide Green) to improve product mix.
- →South Africa mine operations expected to start contributing in H2 FY27, improving competitiveness and gross margins.
- →Domestic sales emphasis planned to offset higher logistics costs in near term.
- →Anticipate 15-20% growth in barium division this year, with continuous R&D for new value-added products.
- →Overall long-term outlook is positive with multiple growth levers and capacity additions supporting medium-term growth.
📈 Profitability & Margins
Rank 1- →Vishnu Chemicals reported over 20% year-on-year growth in both operating revenue and PAT in Q1 FY27, indicating strong growth momentum.
- →The company targets a 20% EBITDA margin over the long term.
- →Growth drivers include capacity additions in specialty chemicals (e.g., DMSO), backward integration in the barium business, scaling up of the strontium segment, and commencing South African operations expected in H2 FY27.
- →Shift towards higher value-added chromium derivatives is expected to improve margins.
- →Despite near-to-medium term headwinds from geopolitical tensions and increased logistics costs, the company remains optimistic about medium-term growth supported by diversified geography and strategic supply agreements.
- →Capex investments of approx. INR 360 crores planned, largely in specialty segments, expected to enhance product mix and revenue.
- →Financial discipline and focus on cost efficiencies (including planned solar power expansion) aim to sustain profitability and EPS growth over time.
🏗️ Capital Expenditure Plans
Yes- →Total capex planned is close to INR360 crores.
- →Over INR200 crores is dedicated to Dimethyl Sulfoxide (DMSO), an import replacement solvent for pharma and agro industries.
- →Significant investment (~INR350 crores) to enhance Chrome Oxide Green production at Vizag plant, utilizing more Sodium Dichromate.
- →Additional marginal capex planned for mine improvements.
- →Past capex (~INR240-250 crores) focused on Chrome Oxide Green expansion and DMSO.
- →Solar power capacity expansion: investing INR5-6 crores to increase solar from 5 MW to 20 MW, aiming for power cost reduction.
- →Backward integration in barium business with capex close to INR40 crores.
- →South Africa mine-related capex limited to INR20-25 crores for refurbishments and starting operations.
- →Strategic long-term supply agreements in chrome business envisaged, associated with capex for value-added products like chrome metal.
💰 Fundraising & Capital Structure
No information- →The company is undertaking a capital expenditure of close to INR360 crores, largely funded through debt.
- →As of March 31, total debt stood at about INR527 crores with a debt-to-equity ratio of 0.49.
- →Management has not shared quarterly debt figures or detailed plans for incremental fundraising.
- →No explicit mention of new equity fundraising on the call.
- →Capex includes INR200+ crores for Dimethyl Sulfoxide (DMSO) project, INR50 crores for chromium derivative expansion, INR20-25 crores for the South Africa mine, and INR40 crores for barium backward integration.
- →Future updates on balance sheet and debt post Q2 results are expected.
- →Debt levels and strategy will be reviewed as capex progresses, but no immediate fresh fundraising was announced.
📋 Order Book & Pipeline
No information- →Vishnu Chemicals has secured a strategic, long-term binding supply agreement for Chrome Oxide Green with fixed volumes set for the next 10 years, providing visibility and stability compared to spot quarterly sales.
- →The company is working on increasing volumes in the export market, as mentioned in recent communications.
- →Production from the South Africa mine is expected to commence by the second half of FY27, which will contribute to future order fulfillment and margin improvements.
- →Ongoing negotiations and customer engagements indicate efforts to pass on increased logistics costs, reflecting active order book management.
- →Expansion capex, including for Dimethyl Sulfoxide (DMSO) and Chrome Oxide Green capacity enhancement, reflects preparedness to meet anticipated demand growth linked to pending orders.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Vishnu Chemicals Q1 FY27 results?
Revenue growth driven by both volume increases and value/realization improvements (Q1 FY27 saw ~25% YoY growth). Vishnu Chemicals reported over 20% year-on-year growth in both operating revenue and PAT in Q1 FY27, indicating strong growth momentum. - The company targets a 20% EBITDA margin over the long term. - Growth drivers include capacity additions in specialty chemicals (e.g., DMSO), backward integration in the barium business, scaling up of the strontium segment, and commencing South African operations expected in H2 FY27. - Shift towards higher value-added chromium derivatives is expected to improve margins. - Despite near-to-medium term headwinds from geopolitical tensions and increased logistics costs, the company remains optimistic about medium-term growth supported by diversified geography and strategic supply agreements. - Capex investments of approx.
What is Vishnu Chemicals share price analysis?
Vishnu Chemicals currently shows a below-average growth signal. The stock trades at a P/E of 28.3 with a market cap of ₹4,236 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vishnu Chemicals planning capital expenditure?
Total capex planned is close to INR360 crores.
Keep Vishnu Chemicals on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.